IPSEY:OTCMKTS
Ipsen ADR Rep 1/4 Ord Shs
$41.90
0.00%
(0.00) 1 دن
30 ستمبر, 2:57:29 PM GMT -4 · USD
search
تمام علامات
| علامت | قیمت | تبدیلی | % تبدیلی |
|---|
insights_autoIPSEY کے لیے سرفہرست بصیرتیں تخلیق کی جا رہی ہیں...
مارکیٹ کی سرمایہ کاری
11.69 ارب
اوسط والیوم
518.00
والیوم
168.00
52 ہفتے میں اعلی
$51.10
52 ہفتے کا کم
$32.68
بی ٹا
0.41
بقایہ شیئرز
33.53 کروڑ
ملازمین کی تعداد
6 ہزار
مارکیٹ کی سرمایہ کاری
11.69 ارب
اوسط والیوم
518.00
والیوم
168.00
52 ہفتے میں اعلی
$51.10
52 ہفتے کا کم
$32.68
بی ٹا
0.41
بقایہ شیئرز
33.53 کروڑ
ملازمین کی تعداد
6 ہزار
خبریں اور کہانیاں
ویب ذرائع اور خبروں کے پارٹنرز سے
Simply Wall Street
·
9 منٹ پہلے
With EPS Growth And More, Sound Group (NASDAQ:SOGP) Makes An Interesting Case
Foreign Policy Journal
·
1 گھنٹہ پہلے
Integra LifeSciences (NASDAQ: IART) Slashes Full-Year 2026 Guidance After Cincinnati Flood Disrupts Manufacturing
Business Insider
·
2 گھنٹے پہلے
The NYSE's Most Famous Floor Trader Says AI Can't Take His Job
Yahoo Finance
·
1 گھنٹہ پہلے
Nasdaq Hits Fresh Ground on Chip and Software Strength as Dow, Small Caps Lag for the Week
پروفائل
Ipsen is a French biopharmaceutical company headquartered in Paris, France, with a focus on drug development and commercialization in three therapeutic areas: oncology, rare diseases and neuroscience. Ipsen is one of the world's top 15 biopharmaceutical companies in terms of oncology sales.
Ipsen, founded by Henri Beaufour in 1929, has approximately 5000 employees worldwide. Ipsen's medicines are registered in 88 countries with direct commercial presence in over 30 countries. Ipsen has 4 global R&D hubs and 3 pharmaceutical development centers around the world. Ipsen has been a family-owned business for the past 90 years and is publicly traded on the Euronext Paris as part of the SBF 120 index. The Beaufour family owns 57% of its shares and 73% of its voting rights, and two of its members, Anne Beaufour and Henri Beaufour, sit on its board of directors. Wikipedia
Ipsen ADR Rep 1/4 Ord Shs کے بارے میں